Navigation Links
PCMA Statement on New Average Manufacturer Price (AMP) Legislation
Date:9/28/2007

WASHINGTON, Sept. 28 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) released the following statement today supporting legislation introduced by Chairman Frank Pallone (D-NJ) of the House Energy and Commerce Subcommittee on Health:

"PCMA applauds the legislation introduced by Chairman Pallone earlier this week that would fix the flawed Average Manufacturer Price (AMP) final rule, mandated under the Deficit Reduction Act.

"PCMA supports the decision to remove PBM retail business rebates and discounts from inclusion in the final AMP rule. However, we remain concerned that mail-service and specialty pharmacy are still included in the definition of AMP. This definition is an inaccurate reflection of the retail class of trade price. Fixing AMP is important so that pharmacists can receive adequate reimbursements in Medicaid, ensuring consumers continued access to their community pharmacies."

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HIV Prevalence In Ethiopian Women Greater Than National Average
2. Average Age of Diabetics Smaller in China
3. Delhis Morbidity Rate Nearly One-sixth of National Average
4. Anti-smoking advertisements to be funded by Cigarette manufacturers
5. Chemists prepare for face-off with manufacturers
6. Clampdown On Fake Drugs Manufacturers In India – New Bill Enacte
7. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
8. Karla: healthy beer as claimed by German manufacturers
9. Imprisonment for fake “baby milk” manufacturers in Chia
10. German Manufacturers Find a Solution for DVT
11. FDA cracks the whip on manufacturers of unapproved Cold Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Crossing the ... last ten minutes of a woman’s life. “Crossing the Bar” is the creation of ... of three children. , Charlotte, who credits the inspiration of the book to ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Some Infallible ... of the Father. “Some Infallible Characteristics of Christ” is the creation of published author, ... of a Baptist Church for thirteen years, a preacher for over nineteen, a pastor ...
(Date:1/22/2017)... Raton, FL (PRWEB) , ... January 22, 2017 , ... ... to customers across the world, recently met with big-name retail buyers at the January ... scientific evidence of efficacy and uses the utmost safety standards in all of its ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company known ... Trade Show in Hilton Head, SC, where it benefited from outstanding meetings with major ... its beauty and wellness products. At this trade show, the company had the chance ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at ... Oat is recognized globally as one of the healthiest cereals, XieQingkui, the founder of ... a move to sow the seed of good karma. Buddhism spirit featuring benevolence and ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23. Januar 2017  ResMed (NYSE: RMD ... 3B Medical ( Winter Haven, Florida ) ... über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien ... ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren an ... 3B leisten, um das in Florida ...
(Date:1/22/2017)... , Saudi Arabia , January 22, 2017 ... US and UAE discuss ... at the World Economic Forum   "The management and ... big data and powered by artificial intelligence and this trend is going to ... ,Hospital of the Future, at the concluding day of the 47 th ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, during ... Conference, "PI3K Pathways in Immunology, Growth Disorders ... (NASDAQ: INFI ) presented preclinical ... candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical ... help overcome resistance to checkpoint inhibition by ...
Breaking Medicine Technology: